BSECompany Update3 Nov 2026 · 3 Nov 2026, 06:09 pm

Vivanza Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2026 ,inter alia, to consider and approve Unaudited Standalone and Consolidated Financial Results along with Limited Review Report of the Company for the Quarter and Half year ended September 30, 2026 and Any other business with the permission of the chair

Vivanza Biosciences Ltd · 530057

✦ AI SummaryResults

Vivanza Biosciences Ltd has postponed and rescheduled its Board meeting to discuss unaudited financial results for the quarter and half year ended September 30, 2026, due to unavoidable circumstances.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Vivanza Biosciences Ltd - 530057 - Board Meeting Intimation for Postponement And Rescheduling Of Board Meeting Pursuant To Regulation 29 & 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

Attachments (1)

📄

cf905575-a106-4fa3-9967-20336b115cd9.pdf

pdf

Download →
View document text
VIVANZA BIOSCIENCES LIMITED Regd. Office: 403, Sarthik 2, Opp. Rajpath Club, S. G. Highway, Ahmedabad 380054. Phone: 079-26870953, email: info@vivanzabiosciences.com, website: www.vivanzabiosciences.com CIN: L24105GJ1982PLC005057 Date: 03rd November,2026 Department of Corporate Services, BSE Limited, Ground Floor, P. J. Towers, Dalal Street, Mumbai – 400001, Scrip Code: 530057 ISIN: INE984E01035 Subject: Intimation regarding Postponement and Rescheduling of Board Meeting pursuant to Regulation 29 & 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Dear Sir/Madam, With reference to the above-captioned subject and pursuant to Regulation 29 and 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the meeting of the Board of Directors of the Company, which was earlier scheduled to be held on Tuesday, November 03rd, 2026, at 03:30 P.M has been postponed and rescheduled due to unavoidable circumstances to Friday, 06th November, 2026 at 03:30 P.M. at the registered office of the Company situated at 403, Sarthik 2, Opp. Rajpath Club, S. G. Highway, Ahmedabad 380054 to discuss and consider, inter-alia: 1. Unaudited Standalone and Consolidated Financial Results along with Limited Review Report of the Company for the Quarter and Half year ended September 30, 2026; 2. Any other business with the permission of the chair; As per Regulation 46 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Intimation of the Board meeting would be made available on the website of the company at: https://vivanzabiosciences.com/announcement/ Further, as already informed, as per the SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended from time to time, and Company's Internal Code for Prohibition of Insider Trading ('Code'), the trading window for dealing in the securities of the Company for the Directors/Officers & Key Managerial Personnel and Designated Persons of the Company defined under the Code has already been closed till the expiry of 48 hours after the declaration of Unaudited Financial Results for the Quarter and Half year ended 30th September, 2026. We request you to take the same on record. Thanking you For Vivanza Biosciences Limited JAYENDRA MEHTA MANAGING DIRECTOR DIN: 08210602